ObesityLIPOXmax-RUNNCT01464073
Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet on the Evolution of Body Fat
A study testing LIPOXmax, 60% VO2peak and Good Medical Practices in people with Obesity, run by Centre Hospitalier Universitaire de la Réunion at 1 site in France.
Trial summary
The purpose of this study is to evaluate the efficacy of 3 of physical exercise training programs, with a supplementation in fruits and vegetables, on body composition. 126 women will be randomized into 3 groups (42 subjects per group). Read more about this study
- Who is it for?
- Ages 20 to 40 years, women only
- Conditions the study is for
- Obesity
- What is being tested?
- LIPOXmax, 60% VO2peak and Good Medical Practices
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 137 participants
- Where
- 1 siteFrance
- Study dates
- Nov 2011to Sep 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 40 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- women
- 20-40 years old
- 27 ≤ BMI ≤40 kg / m²
- sedentary
- considered clinically stable
- able to rehabilitation training
- having signed an informed consent
- without professional activity
Who cannot join
- blood glucose ≥ 1.26 g / l
- HbA1c ≥ 6.5%
- severe hypertension (SBP ≥ 180 mmHg and / or DBP ≥ 110 mmHg)
- hypertension (≥140/90 mmHg) untreated or treated by beta blocker or calcium blocker
- absolute and relative contraindication to the maximal exercise test (ACC / AHA 2002) and / or physical training
- inability to achieve the maximum exercise test and / or the metabolic exercise test by indirect calorimeter
Show all 20Show fewer
- uncompensated cardiovascular and / or respiratory disease revealed by exercise test
- pacemaker or defibrillator
- recent cardiovascular events (heart failure, treated by positive inotropic drugs, angioplasty within the last 10 days, cardiac surgery within the last 3 months, valvular disease requiring surgical correction, evolving myopericarditis, severe ventricular arrhythmias non stabilized under treatment)
- known and documented myopathy
- cancer
- acute and chronic inflammatory disease
- end stage renal disease
- digestive system operation
- treated by corticoids, thyroid hormone, antidepressant or neuroleptics
- pregnancy
- mental deficiency that prevents the understanding of informed consent and protocol
- participation to another research protocol
- attendance in the previous month to a program of rehabilitation training or a diet
- associated evolutionary disease causing significant impairment of general condition.
Trial locations and contacts
1 site in 1 country.
France1 site
Centre Hospitalier Universitaire
Saint-Pierre, Île de La Réunion, 97448
About this study
Official title: Evaluation of the Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet Rich in Fruits and Vegetables, on the Evolution of Body Fat in Overweight or Obese Women, as Part of Type 2 Diabetes Prevention in Reunion Island.
The purpose of this study is to evaluate the efficacy of 3 of physical exercise training programs, with a supplementation in fruits and vegetables, on body composition. 126 women will be randomized into 3 groups (42 subjects per group). The first program will be conducted at a relatively low intensity of effort, corresponding to the maximum rate of lipid oxidation (LIPOXmax)measured by indirect calorimetry. The second program will be at 60% of VO2peak and the third program will be prescribed according to the Good Practices physical Guidelines (30 minutes per day at a moderate intensity). All subjects will receive a free supplement of 5 fruits and vegetables per day during all the intervention. The intervention will last 5 months in total.
Read the detailed description
Background: in Reunion Island, in 2000 the REDIA study showed a prevalence of type 2 diabetes among 30-69 years old people above 17%, a prevalence of obesity among women of 20% and 10% for men. According to the literature upon preventive strategies and/or treatment of metabolic diseases, regular physical activity associated with a balanced diet and an intake of fruits and vegetables, can reduce body fat mass and prevent the complications related to obesity. These complications are partly related to the inflammatory and oxidative stress that accompanies obesity. A diet rich in fruits and vegetables, may improve the inflammatory and oxidative status. However there is no consensus on the intensity of regular physical activity in the practices of prevention and care. These parameters are generally not individualized. International recommendations cover a wide range of exercise intensity (between 40% and 60% of maximal oxygen uptake). The research group of Jacques Mercier (CERAMM Lapeyronie-CHU Montpellier) showed the benefit of the training conducted at a relatively low intensity of effort, corresponding to the maximum rate of lipid oxidation (LIPOXmax), and its effects on the fat mass, the insulin sensitivity and the muscle metabolism, in overweight or obese people.
Main objective: to study the effects of three programs of rehabilitation training associated with a diet supplemented with fruits and vegetables, on reducing body fat in overweight or obese people.
Secondary objectives: to study the effects on the oxidative stress and the inflammatory status, compare the efficacy of these 3 programs of physical training on body composition modifications, insulin sensitivity, lipid utilization during exercise and quality of life, describe feasibility in population (compliance, motivation).
Abstract: according to data from the literature, a balanced diet combined with moderate exercise helps to fight against biological complications related to obesity and to reduce the incidence of type 2 diabetes by promoting fat loss. But there is no consensus on the intensity of physical activity prescribed. Have been shown the benefits of training performed at an individualized intensity of effort, relatively low, corresponding to the maximum rate of lipid oxidation measured by indirect calorimeter (LIPOXmax) on fat loss, sensitivity to insulin and muscle metabolism in obese or diabetic patients. However, an individualized LIPOXmax exercise training has not yet been compared to a standardized training conventionally used in the treatment of obese subjects. Furthermore, no study has yet evaluated the impact of LIPOXmax training on inflammatory and antioxidant status among overweight and obese patients. We propose to compare among overweight or obese patients, the effects of an individualized training at an intensity corresponding to LIPOXmax, the effects of a standardized training to 60% of VO2max, and the effects of a moderate and regular physical activity prescribed according to guidelines of Good Medical Practices.
At M0 participants will have anthropometric and functional examinations and laboratory tests, and will follow nutritional education sessions. They will be then randomized into 3 arms: arm 1 LIPOXmax physical activity, arm 2 60% VO2max physical activity, arm 3 physical activity according to guidelines of Good Medical Practices. Participants of the arms 1 and 2 will practice under the control of a sports instructor; participants of the arm 3 will be regularly monitored by telephone. The procedure will last 5 months. At M3 and M5 anthropometric and biological examinations will be replicated and participants will answer to questionnaires on quality of life and experience of physical activity during and after the intervention.
Primary outcome: body fat mass reduction, in kilograms and in % of total weight.
Secondary outcomes: improvement of biological parameters (markers of inflammation and antioxidant status, blood glucose, HbA1c, insulin, cholesterol, HDL / LDL, triglycerides); improvement in body composition (weight, BMI, waist circumference, hip circumference, muscle mass), and in lipid utilization during exercise; improvement of the quality of life; demonstration of the feasibility in population (adherence, compliance).
Study design: controlled, randomized, of superiority, not blind trial in 126 people divided into three arms of 42 people per arm: arm 1 LIPOXmax intensity of effort, arm 2 60% of VO2max intensity of effort, arm 3 intensity of effort according to the Guidelines of Good Medical Practices.
Intervention: the 126 subjects will undergo the following exams: weight, height, waist and hip circumference, blood pressure, body fat measurement by impedancemetry and biphotonic absorptiometry, maximal cardiopulmonary exercise and effort metabolic test (by indirect calorimeter to determine the LIPOXmax and the crossing points of the substrates), laboratory tests (blood glucose, HbA1c, insulin, cholesterol total, HDL, LDL, triglycerides, CRP, albumin, creatinine, urinary parameters, antioxidant status, inflammatory markers); questionnaires about medical history and sociodemographic data; food survey (frequency questionnaire, quantization by photos), questionnaires on physical activity (Baecke amended), quality of life (SF-36), experience of physical activity. All the participants will have an initial nutritional education session and will receive a free supplement of 5 fruits and vegetables per day during all the intervention, and random urine assays will be performed to monitor the consumption of fruits and vegetables. Participants will be randomized into three arms. Arm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter. Arm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session. Arm 3: control arm. The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 3h30min per week of "moderate" exercise). The intervention will last 5 months in total. For arms 1 and 2: physical activity on ergo meter bicycle controlled by a sports trainer, with the goal of gradual empowerment. For arm 3: self-directed activities with regular telephone follow-up, holding of a book on physical activities and use of a pedometer during walking sessions. Indemnization: all the participants will receive a monthly allowance for the constraints due to their participation.
Number of subjects: to highlight a difference in average change of 1.5 kg fat mass, with a standard deviation of 2.0 kg, a first species risk of 1.67% (5% / 3), a power of 80%, it is necessary to include 38 subjects. In such circumstances it will be possible to demonstrate a theoretical minimum significant difference between arms of: - 2.3% on changes at 5 month of average percentage of body fat (SD = 3%) and - 3.8 kg on changes at 5 months of average weight (SD = 5 kg). Due to missing data (dropouts, lost) rate estimated at 10%, it is planned to include 42 subjects per arm, or 126 in total.
Statistical analysis: single analysis in intention to treat (arms assigned by the randomization). Overall first species risk = 5%. Bilateral formulation of statistical tests. Statistical methods used: bivariate analysis (one factor ANOVA, Pearson Chi2 test or Fisher test), multivariate analysis (ANCOVA, logistic regression). Taking into account the longitudinal data (M0-M3-M5) with generalized estimating equations (GEE). Graphic representation of the evolutions over the study.
- Conditions
- Obesity
- Being tested
- LIPOXmax, 60% VO2peak, Good Medical Practices, supplementation in fruits and vegetables
- Keywords
- NIDDM, obesity, lifestyle intervention, physical exercise, diet, LIPOXmax, FATmax, fat oxydation rate
- Medical subject headings
- Obesity, Diabetes Mellitus, Type 2, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LIPOXmaxBehavioural
Also called FAT oxydation rate, FATmax, FATOXmax
Arm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter.
60% VO2peakBehavioural
Also called physical exercise, exercise training
Arm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session.
Good Medical PracticesBehavioural
Also called physical exercise, exercise training
Arm 3: The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 30min per day of "moderate" exercise).
supplementation in fruits and vegetablesDietary supplement
Also called diet, dietary supplement
all groups will be supplemented in fruits and vegetables (5 per day) during all the study
| Study group | Role | What they receive |
|---|---|---|
| arm 3 : Good Medical Practices | Active comparator | physical exercise at home monitored by telephone (achieving a minimum of 30 minutes per day) Receives: Behavioral: Good Medical Practices; Dietary Supplement: supplementation in fruits and vegetables |
| arm 2 : 60% VO2peak | Active comparator | physical exercise at the intensity of 60% of VO2 peak. 4 times a week. duration will be adjusted for arm 1 and arm 2 have the same total energy expenditure by session. Receives: Behavioral: 60% VO2peak; Dietary Supplement: supplementation in fruits and vegetables |
| arm 1 : LIPOXmax | Experimental | physical exercise at the LIPOXmax intensity during 60 minutes. 4 times a week Receives: Behavioral: LIPOXmax; Dietary Supplement: supplementation in fruits and vegetables |
What is being measured
The primary outcome is the main question the study is designed to answer.
body fat mass reduction
body fat mass will be measured by Dual Energy X-ray absorptiometry (M0 and M5) and by impedencemetry (M0, M3, M5).
Measured: change from baseline in body fat mass at 5 months
Secondary outcomes (10)
oxydative stress and inflammatory status
inflammatory status : TNF alpha, IL-6, Leptin and adiponectin oxydative stress : test Folin-Ciocalteu and test DPPH
Measured: at the inclusion (M0), and at M3 and at the end of the study at M5
biological parameter
blood glucose
Measured: M0, M3, M5
quality of life
quality of life questionaire : Short-Form 36
Measured: M0, M3, M5
feasibility in population
with questionaire about:
- the adherence (number of session of physical activity are completed)
- secondary effects of the physical exercise program (tiredness, joint pain)
Measured: every two weeks
biological parameter
Hb1Ac
Measured: M0, M3, M5
biological parameter
insulinemia (µU/mL)
Measured: M0, M3, M5
biological parameter
total cholesterol
Measured: M0, M3, M5
biological parameter
HDL-C
Measured: M0, M3, M5
biological parameter
LDL-C
Measured: M0, M3, M5
biological parameter
triglyceride
Measured: M0, M3, M5
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Nov 2011 (estimated)
- Study startNov 2011
- Primary completionSep 2012
- Study completionSep 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 137 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de la Réunion
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01464073
- Sponsor's protocol ID
- LIPOXmax
- Acronym
- LIPOXmax-RUN
- Status last verified
- Jul 2015
- First submitted
- 21 Oct 2011
- Last updated
- 29 Jul 2015
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Besnier F, Lenclume V, Gerardin P, Fianu A, Martinez J, Naty N, Porcherat S, Boussaid K, Schneebeli S, Jarlet E, Hatia S, Dalleau G, Verkindt C, Brun JF, Gonthier MP, Favier F. Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Reunion Randomized Controlled Trial. PLoS One. 2015 Nov 10;10(11):e0139246. doi: 10.1371/journal.pone.0139246. eCollection 2015.
PubMed 26555595
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet Rich in Fruits and Vegetables, on the Evolution of Body Fat in Overweight or Obese Women, as Part of Type 2 Diabetes Prevention in Reunion Island.
- ClinicalTrials.gov ID
- NCT01464073
- Acronym / sponsor ID
- LIPOXmax-RUN / LIPOXmax
- Conditions
- Obesity
- Keywords
- NIDDM, obesity, lifestyle intervention, physical exercise, diet, LIPOXmax, FATmax, fat oxydation rate
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 137 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de la RéunionUniversity, hospital or other
- Study start
- Nov 2011
- Primary completion
- Sep 2012 (actual)
- Study completion
- Sep 2012 (actual)
- First posted
- 3 Nov 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the efficacy of 3 of physical exercise training programs, with a supplementation in fruits and vegetables, on body composition. 126 women will be randomized into 3 groups (42 subjects per group). The first program will be conducted at a relatively low intensity of effort, corresponding to the maximum rate of lipid oxidation (LIPOXmax)measured by indirect calorimetry. The second program will be at 60% of VO2peak and the third program will be prescribed according to the Good Practices physical Guidelines (30 minutes per day at a moderate intensity). All subjects will receive a free supplement of 5 fruits and vegetables per day during all the intervention. The intervention will last 5 months in total.
Detailed description
Background: in Reunion Island, in 2000 the REDIA study showed a prevalence of type 2 diabetes among 30-69 years old people above 17%, a prevalence of obesity among women of 20% and 10% for men. According to the literature upon preventive strategies and/or treatment of metabolic diseases, regular physical activity associated with a balanced diet and an intake of fruits and vegetables, can reduce body fat mass and prevent the complications related to obesity. These complications are partly related to the inflammatory and oxidative stress that accompanies obesity. A diet rich in fruits and vegetables, may improve the inflammatory and oxidative status. However there is no consensus on the intensity of regular physical activity in the practices of prevention and care. These parameters are generally not individualized. International recommendations cover a wide range of exercise intensity (between 40% and 60% of maximal oxygen uptake). The research group of Jacques Mercier (CERAMM Lapeyronie-CHU Montpellier) showed the benefit of the training conducted at a relatively low intensity of effort, corresponding to the maximum rate of lipid oxidation (LIPOXmax), and its effects on the fat mass, the insulin sensitivity and the muscle metabolism, in overweight or obese people.
Main objective: to study the effects of three programs of rehabilitation training associated with a diet supplemented with fruits and vegetables, on reducing body fat in overweight or obese people.
Secondary objectives: to study the effects on the oxidative stress and the inflammatory status, compare the efficacy of these 3 programs of physical training on body composition modifications, insulin sensitivity, lipid utilization during exercise and quality of life, describe feasibility in population (compliance, motivation).
Abstract: according to data from the literature, a balanced diet combined with moderate exercise helps to fight against biological complications related to obesity and to reduce the incidence of type 2 diabetes by promoting fat loss. But there is no consensus on the intensity of physical activity prescribed. Have been shown the benefits of training performed at an individualized intensity of effort, relatively low, corresponding to the maximum rate of lipid oxidation measured by indirect calorimeter (LIPOXmax) on fat loss, sensitivity to insulin and muscle metabolism in obese or diabetic patients. However, an individualized LIPOXmax exercise training has not yet been compared to a standardized training conventionally used in the treatment of obese subjects. Furthermore, no study has yet evaluated the impact of LIPOXmax training on inflammatory and antioxidant status among overweight and obese patients. We propose to compare among overweight or obese patients, the effects of an individualized training at an intensity corresponding to LIPOXmax, the effects of a standardized training to 60% of VO2max, and the effects of a moderate and regular physical activity prescribed according to guidelines of Good Medical Practices.
At M0 participants will have anthropometric and functional examinations and laboratory tests, and will follow nutritional education sessions. They will be then randomized into 3 arms: arm 1 LIPOXmax physical activity, arm 2 60% VO2max physical activity, arm 3 physical activity according to guidelines of Good Medical Practices. Participants of the arms 1 and 2 will practice under the control of a sports instructor; participants of the arm 3 will be regularly monitored by telephone. The procedure will last 5 months. At M3 and M5 anthropometric and biological examinations will be replicated and participants will answer to questionnaires on quality of life and experience of physical activity during and after the intervention.
Primary outcome: body fat mass reduction, in kilograms and in % of total weight.
Secondary outcomes: improvement of biological parameters (markers of inflammation and antioxidant status, blood glucose, HbA1c, insulin, cholesterol, HDL / LDL, triglycerides); improvement in body composition (weight, BMI, waist circumference, hip circumference, muscle mass), and in lipid utilization during exercise; improvement of the quality of life; demonstration of the feasibility in population (adherence, compliance).
Study design: controlled, randomized, of superiority, not blind trial in 126 people divided into three arms of 42 people per arm: arm 1 LIPOXmax intensity of effort, arm 2 60% of VO2max intensity of effort, arm 3 intensity of effort according to the Guidelines of Good Medical Practices.
Intervention: the 126 subjects will undergo the following exams: weight, height, waist and hip circumference, blood pressure, body fat measurement by impedancemetry and biphotonic absorptiometry, maximal cardiopulmonary exercise and effort metabolic test (by indirect calorimeter to determine the LIPOXmax and the crossing points of the substrates), laboratory tests (blood glucose, HbA1c, insulin, cholesterol total, HDL, LDL, triglycerides, CRP, albumin, creatinine, urinary parameters, antioxidant status, inflammatory markers); questionnaires about medical history and sociodemographic data; food survey (frequency questionnaire, quantization by photos), questionnaires on physical activity (Baecke amended), quality of life (SF-36), experience of physical activity. All the participants will have an initial nutritional education session and will receive a free supplement of 5 fruits and vegetables per day during all the intervention, and random urine assays will be performed to monitor the consumption of fruits and vegetables. Participants will be randomized into three arms. Arm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter. Arm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session. Arm 3: control arm. The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 3h30min per week of "moderate" exercise). The intervention will last 5 months in total. For arms 1 and 2: physical activity on ergo meter bicycle controlled by a sports trainer, with the goal of gradual empowerment. For arm 3: self-directed activities with regular telephone follow-up, holding of a book on physical activities and use of a pedometer during walking sessions. Indemnization: all the participants will receive a monthly allowance for the constraints due to their participation.
Number of subjects: to highlight a difference in average change of 1.5 kg fat mass, with a standard deviation of 2.0 kg, a first species risk of 1.67% (5% / 3), a power of 80%, it is necessary to include 38 subjects. In such circumstances it will be possible to demonstrate a theoretical minimum significant difference between arms of: - 2.3% on changes at 5 month of average percentage of body fat (SD = 3%) and - 3.8 kg on changes at 5 months of average weight (SD = 5 kg). Due to missing data (dropouts, lost) rate estimated at 10%, it is planned to include 42 subjects per arm, or 126 in total.
Statistical analysis: single analysis in intention to treat (arms assigned by the randomization). Overall first species risk = 5%. Bilateral formulation of statistical tests. Statistical methods used: bivariate analysis (one factor ANOVA, Pearson Chi2 test or Fisher test), multivariate analysis (ANCOVA, logistic regression). Taking into account the longitudinal data (M0-M3-M5) with generalized estimating equations (GEE). Graphic representation of the evolutions over the study.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| arm 3 : Good Medical Practices | Active comparator | Behavioral: Good Medical Practices, Dietary Supplement: supplementation in fruits and vegetablesphysical exercise at home monitored by telephone (achieving a minimum of 30 minutes per day) |
| arm 2 : 60% VO2peak | Active comparator | Behavioral: 60% VO2peak, Dietary Supplement: supplementation in fruits and vegetablesphysical exercise at the intensity of 60% of VO2 peak. 4 times a week. duration will be adjusted for arm 1 and arm 2 have the same total energy expenditure by session. |
| arm 1 : LIPOXmax | Experimental | Behavioral: LIPOXmax, Dietary Supplement: supplementation in fruits and vegetablesphysical exercise at the LIPOXmax intensity during 60 minutes. 4 times a week |
Who may qualify
- Ages
- 20 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- women
- 20-40 years old
- 27 ≤ BMI ≤40 kg / m²
- sedentary
- considered clinically stable
Key exclusion criteria (20 listed)
- blood glucose ≥ 1.26 g / l
- HbA1c ≥ 6.5%
- severe hypertension (SBP ≥ 180 mmHg and / or DBP ≥ 110 mmHg)
- hypertension (≥140/90 mmHg) untreated or treated by beta blocker or calcium blocker
- absolute and relative contraindication to the maximal exercise test (ACC / AHA 2002) and / or physical training
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| LIPOXmaxAlso: FAT oxydation rate, FATmax, FATOXmaxArm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter. | Behavioural | arm 1 : LIPOXmax |
| 60% VO2peakAlso: physical exercise, exercise trainingArm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session. | Behavioural | arm 2 : 60% VO2peak |
| Good Medical PracticesAlso: physical exercise, exercise trainingArm 3: The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 30min per day of "moderate" exercise). | Behavioural | arm 3 : Good Medical Practices |
| supplementation in fruits and vegetablesAlso: diet, dietary supplementall groups will be supplemented in fruits and vegetables (5 per day) during all the study | Dietary supplement | arm 1 : LIPOXmax, arm 2 : 60% VO2peak, arm 3 : Good Medical Practices |
Primary outcome
body fat mass reduction
Time frame: change from baseline in body fat mass at 5 months
body fat mass will be measured by Dual Energy X-ray absorptiometry (M0 and M5) and by impedencemetry (M0, M3, M5).
10 secondary outcomes
oxydative stress and inflammatory status
Time frame: at the inclusion (M0), and at M3 and at the end of the study at M5
biological parameter
Time frame: M0, M3, M5
quality of life
Time frame: M0, M3, M5
feasibility in population
Time frame: every two weeks
biological parameter
Time frame: M0, M3, M5
biological parameter
Time frame: M0, M3, M5
biological parameter
Time frame: M0, M3, M5
biological parameter
Time frame: M0, M3, M5
biological parameter
Time frame: M0, M3, M5
biological parameter
Time frame: M0, M3, M5
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2015.
- Derived from this study: PubMed 26555595Besnier F, Lenclume V, Gerardin P, Fianu A, Martinez J, Naty N, Porcherat S, Boussaid K, Schneebeli S, Jarlet E, Hatia S, Dalleau G, Verkindt C, Brun JF, Gonthier MP, Favier F. Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Reunion Randomized Controlled Trial. PLoS One. 2015 Nov 10;10(11):e0139246. doi: 10.1371/journal.pone.0139246. eCollection 2015.
Related trials for Obesity
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
RecruitingPhase 3
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
Recruiting
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
Overweight, Obesity
RecruitingPhase 1
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Valid MeSH Conditiongs
Not yet recruiting
Prospective Evaluation of Recombinant Pbserum Plus® and Pbserum HA 2.0® in Aesthetic and Regenerative Bioremodeling
Skin Laxity, Localized Adiposity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing LIPOXmax, 60% VO2peak and Good Medical Practices in people with Obesity, run by Centre Hospitalier Universitaire de la Réunion at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 20 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
body fat mass reduction (time frame: change from baseline in body fat mass at 5 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01464073, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2015.